ENDRA Life Sciences
NDRA
3 hedge funds and large institutions have $924K invested in ENDRA Life Sciences in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
186% more capital invested
Capital invested by funds: $323K → $924K (+$601K)
50% more funds holding
Funds holding: 2 → 3 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
ICM Asset Management
Spokane,
Washington
|
+$360K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
FNY Investment Advisers
New York
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IAM
1
ICM Asset Management
Spokane,
Washington
| $400K | +$360K | +4 | New |
|
|
SWM
2
SeaCrest Wealth Management
Purchase,
New York
| $321K | – | – | – |
|
|
WEC
3
Winslow Evans & Crocker
Boston,
Massachusetts
| $62K | – | – | – |
|
|
VF
4
Virtu Financial
New York
| $48K | – | – | – |
|
5
Jane Street
New York
| $36K | – | – | – |
|
|
IFAM
6
Institutional & Family Asset Management
Fort Collins,
Colorado
| $31K | – | – | – |
|
|
TDC
7
Thompson Davis & Co
Richmond,
Virginia
| $19K | – | – | – |
|
8
Morgan Stanley
New York
| $5K | – | – | – |
|
|
AG
9
Advisor Group
Phoenix,
Arizona
| $2K | – | – | – |
|
|
FIA
10
FNY Investment Advisers
New York
| – | -$12K | – | – |
|
NDRA Hedge Fund Activity: Q3 2018 in Review
3 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q3 2018, worth a combined $924K — up 186% from $323K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NDRA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was ICM Asset Management, opening a new position worth an estimated $360K. The largest seller was FNY Investment Advisers, cutting an estimated $12K.
- 3 institutional investors held ENDRA Life Sciences (NDRA) as of Q3 2018, up from 2 in Q2 2018.
- Funds reported $924K of ENDRA Life Sciences stock for Q3 2018, up 186% quarter-over-quarter.
- 1 fund opened new ENDRA Life Sciences positions in Q3 2018 and 0 closed out, a net change of +1 holder.
- The largest ENDRA Life Sciences buyer in Q3 2018 was ICM Asset Management, an estimated $360K added.
- The largest ENDRA Life Sciences seller in Q3 2018 was FNY Investment Advisers, an estimated $12K sold.
Based on aggregated 13F filings for Q3 2018.